Literature DB >> 11810294

Dissecting the epidemiology of a trinucleotide repeat disease - example of FRDA in Finland.

Vesa Juvonen1, Satu-Maria Kulmala, Jaakko Ignatius, Maila Penttinen, Marja-Liisa Savontaus.   

Abstract

Friedreich ataxia (FRDA) is associated with the expansion of a GAA trinucleotide repeat in the first intron of the frataxin (X25) gene. Worldwide it is considered to be the most common form of hereditary ataxia, but it is infrequently encountered in Finland. We have performed the first epidemiological study on the frequency of FRDA in Finland by combining results from a nationwide clinical survey and a molecular carrier testing study. Haplotype analysis was performed for the Finnish FRDA patients and the distribution of frataxin gene GAA repeats was analyzed in controls. In the general population of Finland, the carrier frequency was only 1 in 500, corresponding to a birth incidence of 1 in 10(6). In the more sparsely populated Northern Finland the carrier frequency was five times higher and also four out of the seven Finnish FRDA patients originated from this region. Haplotype analysis revealed the major universal risk haplotype in all the investigated patients. Alleles in the uppermost end of the normal variation (28-36 GAA) were totally missing in the Finnish population. The relative enrichment of the FRDA mutation in the north probably dates back to the internal migration movement and inhabitation of northern Finland in the 1500s. Breaking down the epidemiology of FRDA into clinical and molecular components brings along the possibility of providing more reliable and population-based genetic counseling and recurrence risk estimations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11810294     DOI: 10.1007/s00439-001-0642-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

Review 1.  Finnish Disease Heritage I: characteristics, causes, background.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Variations of frataxin protein levels in normal individuals.

Authors:  Therese Boehm; Barbara Scheiber-Mojdehkar; Britta Kluge; Hans Goldenberg; Franco Laccone; Brigitte Sturm
Journal:  Neurol Sci       Date:  2010-05-27       Impact factor: 3.307

Review 3.  [Etiology, epidemiology, prognosis and biomechanical principles of neuromuscular scoliosis].

Authors:  Nicolas Heinz von der Höh; Stefan Schleifenbaum; Eckehard Schumann; Robin Heilmann; Anna Völker; Christoph-Eckhard Heyde
Journal:  Orthopade       Date:  2021-07-06       Impact factor: 1.087

Review 4.  Diagnosis and treatment of Friedreich ataxia: a European perspective.

Authors:  Jörg B Schulz; Sylvia Boesch; Katrin Bürk; Alexandra Dürr; Paola Giunti; Caterina Mariotti; Francoise Pousset; Ludger Schöls; Pierre Vankan; Massimo Pandolfo
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

5.  Friedreich ataxia (FA) associated with diabetes mellitus type 1 and hyperthrophic cardiomyopathy.

Authors:  Zoran Gucev; Velibor Tasic; Aleksandra Jancevska; Nada Popjordanova; Svetlana Koceva; Marija Kuturec; Vesna Sabolic
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

6.  Friedreich ataxia in Norway - an epidemiological, molecular and clinical study.

Authors:  Iselin Marie Wedding; Mette Kroken; Sandra Pilar Henriksen; Kaja Kristine Selmer; Torunn Fiskerstrand; Per Morten Knappskog; Tone Berge; Chantal M E Tallaksen
Journal:  Orphanet J Rare Dis       Date:  2015-09-04       Impact factor: 4.123

7.  Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.

Authors:  Simonetta Bandiera; François Cartault; Anne-Sophie Jannot; Elie Hatem; Muriel Girard; Laila Rifai; Clemence Loiseau; Arnold Munnich; Stanislas Lyonnet; Alexandra Henrion-Caude
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.